Arca Biopharma Inc (NQ: ABIO )

4.280 USD +0.090 (+2.15%)

Official Closing Price Updated: 2:43 PM EST, Nov 27, 2020 Add to My Watchlist

Price and Volume

Volume	624,478
Open	4.190
Bid (Size)	4.280 (9)
Ask (Size)	4.300 (30)
Prev. Close	4.190
Today's Range	4.190 - 4.450
52wk Range	2.210 - 22.00
Shares Outstanding	13,923,825
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

AB201 Development as a Potential Treatment for COVID-19 Receives U.S. FDA Fast Track Designation

November 23, 2020

ARCA biopharma Announces Third Quarter 2020 Financial Results and Provides Corporate Update

November 02, 2020

Performance

YTD	-24.65%	-24.65%
1 Month	+8.35%	+8.35%
3 Month	-16.08%	-16.08%
6 Month	-77.72%	-77.72%
1 Year	-23.21%	-23.21%

More News

ARCA biopharma Announces FDA Approval of IND Application for AB201 as a Potential Treatment for COVID-19

October 07, 2020

ARCA biopharma Announces Promotion of Chief Medical Officer and Vice President, Regulatory Affairs & Quality

October 05, 2020

ARCA biopharma Announces Submission of IND Application to U.S. FDA for AB201 as a Potential Treatment for COVID-19

September 21, 2020

ARCA Biopharma Announces Completion of FDA Pre-IND Consultation Under Coronavirus Treatment Acceleration Program for AB201 as a Potential Treatment for Severe COVID-19

August 12, 2020

Arca Biopharma Announces Second Quarter 2020 Financial Results and Provides Corporate Update

August 05, 2020

SARS-CoV-2 Cell Entry Mechanisms in Intact Human Heart Published in JACC: Basic to Translational Science by University of Colorado Anschutz Medical Campus and ARCA biopharma Investigators

July 07, 2020

ARCA biopharma Announces Closing of $6.1 Million Registered Direct Offering

June 03, 2020

ARCA Biopharma Announces $9.4 Million Registered Direct Offering

June 01, 2020

A Review Of Changes In Institutional Ownership: $BCDA $POAI $ABIO

August 07, 2020

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.